State of Wyoming Purchases 20,825 Shares of Medifast Inc $MED

Key Points

• The State of Wyoming increased its holdings in Medifast Inc. by 184.1%, acquiring an additional 20,825 shares to total 32,137 shares, valued at approximately $433,000.
• Medifast reported earnings of $0.04 per share, surpassing analysts' expectations of ($0.22), and revenue of $105.56 million for the quarter.
• Institutional investors collectively own 95.51% of Medifast's stock, indicating strong institutional confidence in the company.

State of Wyoming raised its holdings in shares of Medifast Inc (NYSE:MED - Free Report) by 184.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,137 shares of the specialty retailer's stock after buying an additional 20,825 shares during the period. State of Wyoming owned about 0.29% of Medifast worth $433,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. raised its stake in shares of Medifast by 132.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock valued at $3,580,000 after acquiring an additional 151,434 shares in the last quarter. Two Sigma Advisers LP increased its holdings in Medifast by 86.0% during the 4th quarter. Two Sigma Advisers LP now owns 216,000 shares of the specialty retailer's stock worth $3,806,000 after purchasing an additional 99,900 shares during the period. Peapod Lane Capital LLC purchased a new position in Medifast during the 1st quarter worth $933,000. Nuveen LLC bought a new stake in Medifast during the 1st quarter valued at $407,000. Finally, Two Sigma Investments LP lifted its holdings in shares of Medifast by 11.4% in the 4th quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer's stock worth $4,089,000 after buying an additional 23,822 shares during the period. Institutional investors own 95.51% of the company's stock.

Medifast Stock Up 0.3%

Shares of NYSE:MED opened at $14.06 on Friday. The firm has a 50 day moving average of $13.93 and a 200 day moving average of $13.69. The company has a market capitalization of $154.52 million, a price-to-earnings ratio of 43.94 and a beta of 0.80. Medifast Inc has a 52 week low of $11.57 and a 52 week high of $21.98.

Medifast (NYSE:MED - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.26. The firm had revenue of $105.56 million during the quarter, compared to analysts' expectations of $96.10 million. Medifast had a return on equity of 2.00% and a net margin of 0.76%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. On average, sell-side analysts expect that Medifast Inc will post 0.51 EPS for the current year.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.

Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medifast Inc (NYSE:MED - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.